The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Aridis Pharmaceuticals, Inc(NASDAQ:ARDS) 
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (Ig...
Website: http://www.aridispharma.com
Founded: 2003
Full Time Employees: 25
Sector: Healthcare
Industry: Biotechnology
Aridis Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Aridis Pharmaceuticals Op Cashflow Per Share ttm
Aridis Pharmaceuticals Free Cashflow Per Share ttm
Aridis Pharmaceuticals Cash Per Share ttm
Aridis Pharmaceuticals P/S ratio ttm
Aridis Pharmaceuticals (GAAP) P/E ratio ttm
Aridis Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.